Mahinay, Ricardo B.
HRN: 05-92-55 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/07/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
02/07/2023
02/07/2023
IV
300mg
Q6
Dm Foot
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes